ArticleMenopause (New York, N.Y.)2013

Breast cancer susceptibility associated with rs1219648 (fibroblast growth factor receptor 2) and postmenopausal hormone therapy use in a population-based United States study.

Shaneda Warren Andersen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.